Moderna, Inc. Common Stock vs. Novavax Inc
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| MRNA | NVAX | |
|---|---|---|
| Market Cap | $89.83 billion | $2.10 billion |
MRNA leads on 1 of 1 size & scale factors.
Dividend
| MRNA | NVAX | |
|---|---|---|
| Dividend Yield | — | 10.00% |
MRNA and NVAX split the dividend factors evenly.
Risk & Sentiment
| MRNA | NVAX | |
|---|---|---|
| Short Interest | 0.01% | 25.98% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, NVAX overview, NVAX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.